Skip to content

Halozyme Therapeutics Inc

🇩🇪XSTU.RV7GermanyHealthcare

€93.72EURup +1.58 (+1.71%)ClosedEnd of day3:09 AM

Price€93.72+1.58 (+1.71%)

Profile

  • Healthcare
  • Biotechnology
  • Germany

Identity

Exchange
Stuttgart Stock Exchange . XSTU
Type
Stock
ISIN
US40637H1095
CUSIP
Not reported

Company

Employees
423
Headquarters
San Diego, United States
CEO
Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.

Market

Shares outstanding
0
Market cap
Not reported

Highlights

Day range€91.54 - €94.88
today's session
52-week range€52.78 - €95.20
from 249 sessions
Market cap
Not reported
EPS LTM
$3.41
P/E LTM
22.66
Div yield
Not reported

Fundamentals (LTM)

Revenue
$1.66B+41.15%up year on year
Net income
$413.6M-25.78%down year on year
Gross margin
78.18%-3.7%down year on year
Free cash flow
$806.22M+49.11%up year on year

View all financials

Other listings

These are the venues Finzer covers, not every venue that exists.

Business summary

No company summary reported yet.